TerminatedPhase 2NCT00624975

Safety and Immunogenicity of Peru-15 Vaccine When Given With Measles Vaccine in Healthy Indian and Bangladeshi Infants

Studying Cholera

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
International Vaccine Institute
Principal Investigator
John Clemens, MD
International Vaccine Insititute
Intervention
Peru-15 Vaccine(biological)
Enrollment
74 enrolled
Eligibility
All sexes
Timeline
2008 – 2012

Study locations (2)

Collaborators

International Centre for Diarrhoeal Disease Research, Bangladesh · Christian Medical College, Vellore, India · Avant Immunotherapeutics · Vaccine Technologies Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00624975 on ClinicalTrials.gov

Other trials for Cholera

Additional recruiting or active studies for the same condition.

See all trials for Cholera →

← Back to all trials